| Issue |
J Oral Med Oral Surg
Volume 28, Number 4, 2022
|
|
|---|---|---|
| Article Number | 47 | |
| Number of page(s) | 4 | |
| DOI | https://doi.org/10.1051/mbcb/2022029 | |
| Published online | 21 December 2022 | |
Case Report
Recurrent labial xanthoma infection in a patient with Neurofibromatosis-Noonan syndrome: case report and literature review
1
Department of Oral Surgery, CHU Caen, France
2
Department of Maxillofacial Surgery, CHU Caen, France
* Correspondence: paulinedussueil@hotmail.com
Received:
22
June
2022
Accepted:
21
September
2022
Introduction: Noonan Syndrome is a clinically and genetically heterogeneous syndrome, characterized by marked phenotypic variability. All the clinical manifestations of this syndrome are still not fully known. Observation: We present the case of a 58-year-old woman with a diagnosis of Neurofibromatosis-Noonan syndrome with SOS2 mutation, observed by her general practitioner for a recurrent left upper lip abscess despite drainage and antibiotic therapy. The anatomo-pathological result of the sample was in favor of an infected xanthoma. Discussion: The most common oral manifestation of Noonan syndrome includes malocclusion, dental anomalies and radiologic jaw lesions. Xanthomas of the lip have never been reported in this syndrome. Conclusion: Oral xanthomas could be one of the many oral clinical manifestations of Noonan Syndrome. However, more research is needed to understand clinical consequences of mutations in identified genes.
Key words: Noonan syndrome / neurofibromatosis
© The authors, 2022
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Introduction
Noonan syndrome (NS) is a multisystemic autosomal dominant disorder, clinically and genetically heterogeneous, with an incidence of 1:1000–2500 live births [1]. It is the most common entity among a group of pathologies called “RASopathies”, caused by dysregulation of the RAS-MAPK pathway, an important signaling pathway for cell proliferation, differentiation, survival and apoptosis [2]. This pathway also participates in organogenesis, morphology determination, and growth [3].
Neurofibromatosis-Noonan syndrome describes the association of features of Noonan syndrome and neurofibromatosis type 1, which have a common pathogenic mechanism [4].
Among the clinical manifestations of these pathologies, rare skin anomalies reported in Noonan syndrome include xanthomas of skin and tongue. However, prior to this patient, lip xanthoma and infected xanthoma have not been reported yet in any other cases.
Herein, we describe the case of a patient who was referred to the Oral surgery department by her general practitioner.
Observation
A 58-year-old woman was admitted to the Oral surgery department of Caen University Hospital, for a recurrent upper lip abscess.
The patient had a history of Neurofibromatosis-Noonan Syndrome with SOS2 mutation, including distinctive facial appearance, short stature, chronic lymphedema, combined with thoracic and spinal neurofibromas. She also had periorbital xanthelasma.
The clinical examination revealed swollen lips, due to known chronic lymphedema, with healthy surrounding skin. The upper lip was inflammatory, with an intraoral fistula. Through this fistula, a yellowish lesion was noticeable (Fig. 1).
There were no signs of dental infections, and the patient showed an unremarkable oral condition. The oral mucosa was within normal limits. There was no history of smoking or trauma.
As the blood test showed no sign of coagulation defect, we decided to perform an excision biopsy after draining the abscess (Fig. 2). Several diagnoses were suspected, including diagnoses of mucoid cyst, lipoma or sebaceous cyst.
The resection specimen was fixed in 10% buffered formalin and then embedded in paraffin, which was then treated with hematoxylin and eosin (H&E) using routine laboratory protocol.
Histological analyses were in favor of a xanthoma.
A blood test was done, including a blood lipid profile, which did not show any abnormalities.
No further treatment was conducted. A control at 3 weeks showed resolution of symptoms.
The patient was then lost to follow-up.
The patient came back to the Oral surgery department 2 years later, with a recurrence of the lesion in the exact same area. She had an upper lip abscess, which was drained and treated with antibiotics.
Another excision biopsy was performed with the previous protocol. Immunohistochemistry studies were realized showing a CD68 negative sample. Histological analysis was again in favor of a xanthoma (Fig. 3).
A new blood test was done, and the results were similar to previous ones. Thus, a yearly follow-up was advised to the patient, which is still uneventful to this day (4 years after the first visit).
 |
Fig. 1 Swollen lips with a predominant area in the upper left lip, and intraoral fistula with a yellowish aspect of the lesion. |
 |
Fig. 2 Excision biopsy showing a rather well defined yellow tissue lesion surrounded by inflammatory tissue, located in the labial mucosa. |
 |
Fig. 3 Views of the lesion with HES and immunohistochemistry with CD68 marking, showing foamy macrophages within a fibrous stroma. Cells are CD68 negative. |
Discussion
NS was described by pediatric cardiologist Jacqueline Noonan, and is characterized by a phenotypic variability that also changes with time [5]. Thus, it is difficult to diagnose in some cases, especially in adulthood.
Moreover, clinical features of this syndrome can overlap with others from related disorders (such as Neurofibromatosis as seen in this case, Leopard syndrome, etc.) [6]. Among clinical manifestations of this syndrome, short stature, characteristic facial features, congenital cardiac defect, musculoskeletal abnormalities are often found.
The final diagnostic of NS can be done with the help of molecular testing. Nowadays, molecular testing diagnoses up to 75% of the NS. It also potentially provides genotype-phenotype correlations [3].
Early diagnosis of this syndrome is highly recommended, because of cardiac issues and neoplasm predisposition [7].
Therefore, SOS2 was recently described as a causative gene of NS. SOS2 mutations are associated with clinical manifestations resembling those found in SOS1 mutations, with a high rate of ectodermal and lymphatic anomalies and less cases of short stature and cognitive impairment than in the general NS population [8]. There is only few information about genotype-phenotype correlations with SOS2-related NS, as a causal link between a missense mutation in this gene and NS has only just been established. As a result, several clinical expressions, potentially suggestive of NS, are still not fully known.
Several intraoral manifestations have been reported in NS, such as dental anomalies and malocclusion [9], high arched palate [10], distinctive philtrum, full lips [11], radiologic jaw lesion (such as central giants central lesions (CGCLs) [7]).
Xanthoma is a xanthogranulomatous reaction, presenting as yellow-brown well circumscribed macules or papules, as a result of yellow pigments accumulation in the skin. It has rarely been described in Noonan Syndrome, occurring in the skin, tongue and in oral mucous membranes [12,13]. This pathology is often related to a disorder in lipid metabolism. Histological analysis shows lipid-rich foamy macrophages in the dermis [14]. It occurs mainly in patients with metabolic or endocrine disorders.
Olson et Al. recently reported that central xanthoma of the jaw could be a manifestation of NS. It was not associated with hyperlipidemia unlike extragnathic xanthomas, and there was no association with trauma or infection [15].
In our patient, there was no sign of hyperlipidemia, and the blood lipid profile was normal. However, the histological analysis showed CD68 negative cells, unlike Olson's case, which is usually expressed by the monocyte lineage or macrophages.
The link between NS and xanthomas occurring without metabolic disorders or hyperlipidemia remains to be confirmed.
Conclusion
This is the first report to date of a labial xanthoma in NS.
We believe that lip xanthomas, could be related to NS and can be considered as another suggestive oral feature of Noonan syndrome.
Little is known about genotype–phenotype correlations with SOS2-related Noonan syndrome, as only a few cases have been published. More research is needed to understand clinical consequences of mutations in identified genes.
Conflicts of interest
The authors declare that they have no conflicts of interest in relation to this article.
Informed consent
Written informed consent was obtained from the patient.
Ethical approval
Ethical approval was note required.
Source of funding
This research did not receive any specific funding.
References
- Sinha SK, Diaz-Thomas A. Endocrinopathies Associated With Noonan Syndrome. In: Noonan Syndrome. Elsevier 2019. p. 49–60. [Google Scholar]
- Lissewski C, Chune V, Pantaleoni F, De Luca A, Capri Y, Brinkmann J, et al. Variants of SOS2 are a rare cause of Noonan syndrome with particular predisposition for lymphatic complications. Eur J Hum Genet 2021;29:51–60. [CrossRef] [PubMed] [Google Scholar]
- Zadeh N. Noonan syndrome: phenotypic variations and molecular genetics. In: Noonan Syndrome. Elsevier 2019. p. 1–14. [Google Scholar]
- Reig I, Boixeda P, Fleta B, Morenoc C, Gámez L, Truchuelo M. Neurofibromatosis-Noonan syndrome: case report and clinicopathogenic review of the Neurofibromatosis-Noonan syndrome and RAS-MAPK pathway. Dermatol Online J 2011;17. [CrossRef] [Google Scholar]
- Tartaglia M, Gelb BD, Zenker M. Noonan syndrome and clinically related disorders. Best Pract Res Clin Endocrinol Metab 2011;25:161–179. [CrossRef] [PubMed] [Google Scholar]
- Tartaglia M, Zampino G, Gelb BD. Noonan syndrome: clinical aspects and molecular pathogenesis. Mol Syndromol 2010;1:2–26. [Google Scholar]
- Friedrich RE, Scheuer HA. Sequential loss of mandibular permanent incisors in Noonan syndrome. In Vivo 2022;36:1021–1029. [CrossRef] [PubMed] [Google Scholar]
- Cordeddu V, Yin JC, Gunnarsson C, Virtanen C, Drunat S, Lepri F, et al. Activating mutations affecting the Dbl homology domain of SOS2 cause noonan syndrome. Hum Mutat 2015;36:1080–1087. [CrossRef] [PubMed] [Google Scholar]
- Lutz JC, Nicot R, Schlund M, Schaefer E, Bornert F, Fioretti F, et al. Dental and maxillofacial features of Noonan Syndrome: case series of ten patients. J Cranio-Maxillofac Surg 2020;48:242–250. [CrossRef] [Google Scholar]
- Noonan JA. Noonan syndrome and related disorders. Prog Pediatr Cardiol 2005;20:177–185. [Google Scholar]
- Romano AA, Allanson JE, Dahlgren J, Gelb BD, Hall B, Pierpont ME, et al. Noonan syndrome: clinical features, diagnosis, and management guidelines. Pediatrics 2010;126:746–759. [Google Scholar]
- Zenker M, éditeur. Noonan syndrome and related disorders: a matter of deregulated ras signaling. Basel; New York: Karger 2009. 167 p. (Monographs in human genetics). [Google Scholar]
- Mahathi N. Inflammatory Pseudotumor and/or Xanthoma involving the maxilla and maxillary sinus: an unusual case report. Int J Dent Oral Sci 2021;2286–2290. [Google Scholar]
- Blessing K. Cutaneous granulomatous inflammation. Curr Diagn Pathol. 2005;11:219–235. [CrossRef] [Google Scholar]
- Olson NJ, Addante RR, de Abreu FB, Memoli VA. Central xanthoma of the jaw in association with Noonan syndrome. Hum Pathol 2018;82:202–205. [CrossRef] [PubMed] [Google Scholar]
All Figures
|
Fig. 1 Swollen lips with a predominant area in the upper left lip, and intraoral fistula with a yellowish aspect of the lesion. |
| In the text | |
|
Fig. 2 Excision biopsy showing a rather well defined yellow tissue lesion surrounded by inflammatory tissue, located in the labial mucosa. |
| In the text | |
|
Fig. 3 Views of the lesion with HES and immunohistochemistry with CD68 marking, showing foamy macrophages within a fibrous stroma. Cells are CD68 negative. |
| In the text | |
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.